190 related articles for article (PubMed ID: 27385218)
1. SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice.
Ke M; Wang H; Zhou Y; Li J; Liu Y; Zhang M; Dou J; Xi T; Shen B; Zhou C
Oncotarget; 2016 Aug; 7(31):49509-49526. PubMed ID: 27385218
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo.
Xie X; Zhou Y; Wang X; Guo J; Li J; Fan H; Dou J; Shen B; Zhou C
Carbohydr Polym; 2017 Oct; 173():360-371. PubMed ID: 28732877
[TBL] [Abstract][Full Text] [Related]
3. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo.
Xie X; Ma L; Zhou Y; Shen W; Xu D; Dou J; Shen B; Zhou C
Carbohydr Polym; 2019 Dec; 225():115223. PubMed ID: 31521276
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
Zhao L; Wang WJ; Zhang JN; Zhang XY
Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
[TBL] [Abstract][Full Text] [Related]
6. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
7. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICA.
Wan LL; Zhang DQ; Zhang JN; Ren LQ
J Zhejiang Univ Sci B; 2017 Jun; 18(6):522-531. PubMed ID: 28585428
[TBL] [Abstract][Full Text] [Related]
9. Effective inhibition of a Strongylocentrotus nudus eggs polysaccharide against hepatocellular carcinoma is mediated via immunoregulation in vivo.
Wang M; Wang H; Tang Y; Kang D; Gao Y; Ke M; Dou J; Xi T; Zhou C
Immunol Lett; 2011 Dec; 141(1):74-82. PubMed ID: 21893096
[TBL] [Abstract][Full Text] [Related]
10. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A
Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
13. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
14. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
[TBL] [Abstract][Full Text] [Related]
15. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway.
Zou X; Liang J; Sun J; Hu X; Lei L; Wu D; Liu L
J Pharmacol Sci; 2016 Aug; 131(4):233-40. PubMed ID: 27177453
[TBL] [Abstract][Full Text] [Related]
16. The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice.
Aketa H; Tatsumi T; Kohga K; Tsunematsu H; Aono S; Shimizu S; Kodama T; Nawa T; Shigekawa M; Hikita H; Sakamori R; Hosui A; Miyagi T; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2013 Sep; 133(5):1126-34. PubMed ID: 23420533
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.
Ou ZL; Luo Z; Wei W; Liang S; Gao TL; Lu YB
RNA Biol; 2019 Nov; 16(11):1592-1603. PubMed ID: 31402756
[TBL] [Abstract][Full Text] [Related]
18. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil and interferon-α immunochemotherapy enhances immunogenicity of murine pancreatic cancer through upregulation of NKG2D ligands and MHC class I.
Khallouf H; Märten A; Serba S; Teichgräber V; Büchler MW; Jäger D; Schmidt J
J Immunother; 2012 Apr; 35(3):245-53. PubMed ID: 22421942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
